Picture of Torrent Pharmaceuticals logo

TORNTPHARM — Torrent Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India New Issue-Torrent Pharma to sell largest acquisition-funding debt this FY, bankers say

MUMBAI, Jan 14 (Reuters) - India's Torrent Pharmaceuticals TORP.NS plans to raise 110 billion rupees ($1.22 billion) through multiple maturity bonds in what would be the largest acquisition-funding deal so far this financial year, two bankers said on Wednesday.

The company plans to raise 20 billion rupees through two-year bonds, 25 billion rupees through three-year bonds, 30 billion rupees through four-year papers and 35 billion rupees through a five-year debt, the bankers said.

The company has invited commitment bids for all issues on Friday, and has tied up with large mutual funds and pension funds as anchor investors.

Torrent is raising funds for acquiring a controlling stake in JB Chemicals & Pharmaceuticals. The company will acquire a controlling stake in JB at an equity valuation of about 257 billion rupees on a fully diluted basis, to be followed by a merger of the two companies.

Torrent Pharma did not reply to a Reuters email seeking comment.

 Here is the list of deals reported so far on January 14:

IssuerTenureCoupon (in %)Issue size (in bln rupees)*Bidding dateRating
Torrent Pharmaceuticals2 years7.4520January 16AA+ (India Ratings, Icra
Torrent Pharmaceuticals3 years7.6025January 16AA+ (India Ratings, Icra
Torrent Pharmaceuticals4 years7.6030January 16AA+ (India Ratings, Icra
Torrent Pharmaceuticals5 years7.8035January 16AA+ (India Ratings, Icra
*Size includes base plus greenshoe for some issues ($1 = 90.0438 Indian rupees) (Reporting by Dharamraj Dhutia; Editing by Sherry Jacob-Phillips) ((Dharamraj.dhutia@tr.com))

Recent news on Torrent Pharmaceuticals

See all news